HER2 testing and correlation with efficacy of trastuzumab therapy - The Fornier et al article reviewed

被引：0
|
作者：
Spigel, DR [1 ]
Burstein, HJ [1 ]
机构：
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med,Dana Farber Canc Inst, Dept Med,Div Med Oncol,Breast Oncol Ctr, Boston, MA 02115 USA
来源：
ONCOLOGY-NEW YORK | 2002年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1352 / +
页数：3
相关论文
共 50 条
  • [21] Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer (MBC) patients in Sweden
    Lidgren, M.
    Rehnberg, C.
    Wilking, N.
    Jonsson, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification
    Seidman, AD
    Fornier, MN
    Esteva, FJ
    Tan, L
    Kaptain, S
    Bach, A
    Panageas, KS
    Arroyo, C
    Valero, V
    Currie, V
    Gilewski, T
    Theodoulou, M
    Moynahan, ME
    Moasser, M
    Sklarin, N
    Dickler, M
    D'Andrea, G
    Cristofanilli, M
    Rivera, E
    Hortobagyi, GN
    Norton, L
    Hudis, CA
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2587 - 2595
  • [23] Impact of prior (neo)adjuvant trastuzumab exposure on the efficacy of HER2 targeted therapy for metastatic breast cancer
    Kanjanapan, Yada
    Tran, Dan
    Lok, Sheau Wen
    Gibbs, Peter
    De Boer, Richard
    Yeo, Belinda
    Greenberg, Sally
    Barnett, Frances
    Knott, Louise
    Richardson, Gary
    Wong, Rachel
    Nottage, Michelle
    Collins, Ian
    Torres, Javier
    Lombard, Janine
    Johns, Julie
    Harold, Michael
    Malik, Laeeq
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.
    Antolin, Silvia
    Garcia-Caballero, Lucia
    Reboredo, Cristina
    Molina Diaz, Aurea
    Mosquera, Joaquin
    Vazquez-Boquete, Angel
    Gallego, Rosalia
    Paz Santiago, Maria
    Concha, Angel
    Eva Perez, Maria
    Calvo, Lourdes
    Garcia-Caballero, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    LABORATORY INVESTIGATION, 2011, 91 : 62A - 62A
  • [26] Her2 Status Following Neoadjuvant Trastuzumab Therapy for Primary Breast Cancer
    Sanders, M. A. G.
    Richardson, A. L.
    Ly, A.
    MODERN PATHOLOGY, 2011, 24 : 62A - 62A
  • [27] Maintenance Therapy with Trastuzumab in Her2 Positive Metastatic Parotid Ductal Adenocarcinoma
    Iqbal, Muhammad Shahid
    Shaikh, Ghazia
    Chatterjee, Sanjoy
    Cocks, Helen
    Kovarik, Josef
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2014, 2014
  • [28] Level of HER2 amplification correlates with response to trastuzumab-based therapy
    Nature Clinical Practice Oncology, 2008, 5 (2): : 68 - 68
  • [29] Metastatic breast cancer: A regional audit of HER2 testing and trastuzumab access.
    Scullin, P.
    Drake, A. T.
    Coyle, V. M.
    McAleer, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 324S - 324S
  • [30] HER2 Testing and Subsequent Trastuzumab Treatment for Breast Cancer in a Managed Care Environment
    Barron, John J.
    Cziraky, Mark J.
    Weisman, Thomas
    Hicks, David G.
    ONCOLOGIST, 2009, 14 (08): : 760 - 768
12345